Arzneikatalog

Features Arzneikatalog

Now also with DocCheck login!The popular drug catalog as an app offers you up-to-date, clear and free access to comprehensive information on over 1,200 ratiopharm and TEVA drugs as well as 500 active ingredients.
You can quickly access our practical lists, such as divisibility / suspendability or antibiotics overview.
The drug search gives you all the data from price to appearance to medical information.
Automatic 14-day updates ensure that it is up-to-date.
The app is free of charge for you, all you need to do to use it is a one-time login with your DocCheck access or specialist group access (available at: fachkreis.ratiopharm.de).This is what our drug catalog offers you:Quick access to our clear listsFor our ratiopharm medicines, information on these topics can be found:- Divisibility / suspendability- Pregnancy and breast feeding period- Special ingredients: lactose, fructose, sorbitol, gelatine- Preparations containing ethanol: Information on the ethanol content and alcohol-free alternatives- Overview of antibiotics: indication, resistance, information on pregnancy and breastfeeding- Substitution exclusion list of the Federal Joint CommitteeDrug searchYou can easily find our ratiopharm and TEVA drugs by searching for PZN, product or active ingredient name or by indication and pre-filtered symptoms.All important information is shown at a glance:- Pharmacy sales price in euros- pack sizes- Pharmaceutical central number (PZN)- Dosage form with a detailed illustration including diameter, height and weight- ATC code- OTC, RX or BTM- Active ingredient and other ingredients- Information on special ingredients gelatine, lactose (in mg), fructose, sorbitol and animal ingredients- Divisibility, mortarability and suspensibility- Pregnancy and breast feeding period- Storage and shelf life / shelf life after opening- Antibiotics: indications and resistance- Technical information and instructions for use- Red hand letter- training material- Answers to frequently asked questions (Standard Response Letter)Status: 01.11.2021